0000897069-24-000269.txt : 20240208 0000897069-24-000269.hdr.sgml : 20240208 20240208163043 ACCESSION NUMBER: 0000897069-24-000269 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240207 FILED AS OF DATE: 20240208 DATE AS OF CHANGE: 20240208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Young David CENTRAL INDEX KEY: 0001378166 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39531 FILM NUMBER: 24609550 MAIL ADDRESS: STREET 1: 8850 STANFORD BOULEVARD STREET 2: SUITE 2500 CITY: COLUMBIA STATE: MD ZIP: 21045 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Processa Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001533743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 451539785 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 BUSINESS PHONE: 443-776-3133 MAIL ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 FORMER COMPANY: FORMER CONFORMED NAME: Heatwurx, Inc. DATE OF NAME CHANGE: 20111028 4 1 form4.xml X0508 4 2024-02-07 0001533743 Processa Pharmaceuticals, Inc. PCSA 0001378166 Young David C/O PROCESSA PHARMACEUTICALS, INC. 7380 COCA COLA DRIVE, SUITE 106 HANOVER MD 21076 true true Pres. Research & Development false Common Stock 2024-02-07 4 P 0 21000 2.4536 A 79387 D Common Stock 30985 I By Young-Plaisance Revocable Trust Common Stock 10786 I By Family Entities Common Stock 18544 I By CorLyst, LLC /s/ David Young by Michael B. Kirwan, as Attorney-in-Fact 2024-02-08